Fenofibrate and cholestasis Patient Reports February 11, 2012

Fenofibrate Side Effects Report #5201691-8
Fenofibrate side effect was reported by a Physician from SPAIN on Dec 18, 2006. Female patient, 60 years of age, was diagnosed with hypertriglyceridaemia, osteoporosis , prophylaxis and was treated with Fenofibrate. After drug was administered, patient experienced the following side effects: cholelithiasis, cholestasis, chromaturia, hepatic necrosis, hepatocellular damage, jaundice , laboratory test abnormal, lymphocyte percentage decreased, prurigo. Fenofibrate dosage: 250 MG Q DAY. During the same period patient was treated with RALOXIFENE. Patient was hospitalized. Patient recovered.

Fenofibrate Side Effects Report #5332894-X
Fenofibrate side effect was reported by a Health Professional from SPAIN on May 04, 2007. Female patient, 60 years of age, was diagnosed with hypertriglyceridaemia, osteoporosis  and was treated with Fenofibrate. After drug was administered, patient experienced the following side effects: biopsy liver abnormal, cholelithiasis, cholestasis, chromaturia, erythema multiforme, hepatic necrosis, hepatitis , immunology test abnormal. Fenofibrate dosage: 250 MG, QD. During the same period patient was treated with RALOXIFENE. Patient was hospitalized. Patient recovered.

Fenofibrate Side Effects Report #5341393-0
Fenofibrate side effect was reported by a Health Professional from SPAIN on May 16, 2007. Female patient, 60 years of age, was diagnosed with hypertriglyceridaemia, osteoporosis prophylaxis and was treated with Fenofibrate. After drug was administered, patient experienced the following side effects: cholelithiasis, cholestasis, chromaturia, hepatic necrosis, lymphopenia, prurigo, rash morbilliform, white blood cell count increased. Fenofibrate dosage: (250 MG QD). During the same period patient was treated with RALOXIFENE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Fenofibrate Side Effects Report #5345395-X
Fenofibrate side effect was reported by a Health Professional from SPAIN on May 16, 2007. Female patient, 60 years of age, was diagnosed with hypertriglyceridaemia, osteoporosis  and was treated with Fenofibrate. After drug was administered, patient experienced the following side effects: cholestasis, hepatic necrosis, hepatitis acute, hepatotoxicity, lymphopenia, white blood cell count decreased. Fenofibrate dosage: (250 MG QD). During the same period patient was treated with RALOXIFENE. Patient was hospitalized. Patient recovered.


Fenofibrate Side Effects Report #5112549-7
Fenofibrate side effect was reported by a Consumer or non-health professional from FRANCE on Sept 12, 2006. Female patient, 60 years of age, was diagnosed with hypertriglyceridaemia, osteoporosis prophylaxis and was treated with Fenofibrate. After drug was administered, patient experienced the following side effects: cholestasis, erythema, hepatocellular damage, hepatotoxicity, investigation abnormal. Fenofibrate dosage: unknown. During the same period patient was treated with RALOXIFENE. Patient was hospitalized. Patient recovered.

Fenofibrate Side Effects Report #5140581-6
Fenofibrate side effect was reported by a Consumer or non-health professional from on Oct 10, 2006. Female patient, 60 years of age, was diagnosed with hypertriglyceridaemia, osteoporosis prophylaxis and was treated with Fenofibrate. After drug was administered, patient experienced the following side effects: cholelithiasis, cholestasis, chromaturia, erythema, hepatic necrosis, hepatitis , prurigo, rash morbilliform. Fenofibrate dosage: 250 MG, DAILY,PO. During the same period patient was treated with RALOXIFENE. Patient was hospitalized. Patient recovered.

Fenofibrate Side Effects Report #5571931-4
Fenofibrate side effect was reported by a Health Professional from GERMANY on Dec 14, 2007. Male patient, 65 years of age, was diagnosed with hyperlipidaemia and was treated with Fenofibrate. After drug was administered, patient experienced the following side effects: cholestasis. Fenofibrate dosage: unknown. During the same period patient was treated with CANDESARTAN CILEXETIL, TAMSULOSIN, AMLODIPINE BESYLATE, LANSOPRAZOLE, PRAVASTATIN. Patient was hospitalized. Patient recovered.

Fenofibrate Side Effects Report #4641651-9
Fenofibrate side effect was reported by a Consumer or non-health professional from on Mar 29, 2005. Male patient, 66 years of age, was diagnosed with dyslipidaemia, hypertension, hyperuricaemia, portal vein thrombosis and was treated with Fenofibrate. After drug was administered, patient experienced the following side effects: cheilitis, cholestasis, cytolytic hepatitis, erythema multiforme, eyelid oedema, pruritus, purpura, rash papular. Fenofibrate dosage: unknown. During the same period patient was treated with CANDESARTAN CILEXETIL, ALLOPURINOL, FLUINDIONE. Patient was hospitalized. Patient recovered.